The U -shape Relationship Between Free Fatty Acid Level and Adverse Outcomes in Coronary Artery Disease Patients with Hypertension: Evidence from a Large Prospective Cohort Study

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2024 Sep 10

PMID 39256835

Authors

Ting-Ting Wu

Ying Pan

Ying-Ying Zheng

Zhi-Long Wang

Chang-Jiang Deng

Shun Wang

Xiang Xie

Affiliations

Soon will be listed here.

Abstract

Background: Evidence is scarce on the effect of free fatty acid (FFA) level in the prognosis of coronary artery disease (CAD) patients with hypertension. This study.

Methods: A large prospective cohort study with a follow-up period of average 2 years was conducted at Xinjiang Medical University Affiliated First Hospital from December 2016 to October 2021. A total of 10,395 CAD participants were divided into groups based on FFA concentration and hypertension status, and then primary outcome mortality and secondary endpoint ischemic events were assessed in the different groups.

Results: A total of 222 all-cause mortality (ACMs), 164 cardiac mortality (CMs), 718 major adverse cardiovascular events (MACEs) and 803 major adverse cardiovascular and cerebrovascular events (MACCEs) were recorded during follow-up period. A nonlinear relationship between FFA and adverse outcomes was observed only in CAD patients with hypertension. Namely, a "U -shape" relationship between FFA levels and long-term outcomes was found in CAD patients with hypertension. Lower FFA level (< 310 µmol/L), or higher FFA level (≥ 580 µmol/L) at baseline is independent risk factors for adverse outcomes. After adjustment for confounders, excess FFA increases mortality (ACM, HR = 1.957, 95%CI(1.240-3.087), P = 0.004; CM, HR = 2.704, 95%CI(1.495-4.890, P = 0.001) and MACE (HR = 1.411, 95%CI(1.077-1.848), P = 0.012), MACCE (HR = 1.299, 95%CI (1.013-1.666), P = 0.040) prevalence. Low levels of FFA at baseline can also increase the incidence of MACE (HR = 1.567,95%CI (1.187-2.069), P = 0.002) and MACCE (HR = 1.387, 95%CI (1.070-1.798), P = 0.013).

Conclusions: Baseline FFA concentrations significantly associated with long-term mortality and ischemic events could be a better and novel risk biomarker for prognosis prediction in CAD patients with hypertension.

Trial Registration: The details of the design were registered on https://www.chictr.org.cn/ (Identifier NCT05174143).

References

Gerich J . Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc. 2003; 78(4):447-56. DOI: 10.4065/78.4.447. View

Yuan D, Xu N, Song Y, Zhang Z, Xu J, Liu Z . Association Between Free Fatty Acids and Cardiometabolic Risk in Coronary Artery Disease: Results From the PROMISE Study. J Clin Endocrinol Metab. 2023; 109(1):125-134. DOI: 10.1210/clinem/dgad416. View

Jin J, Cao Y, Liu H, Zhang H, Guo Y, Wu N . Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status. Cardiovasc Diabetol. 2019; 18(1):134. PMC: 6791018. DOI: 10.1186/s12933-019-0936-8. View

Brenner C, Galluzzi L, Kepp O, Kroemer G . Decoding cell death signals in liver inflammation. J Hepatol. 2013; 59(3):583-94. DOI: 10.1016/j.jhep.2013.03.033. View

Mills K, Stefanescu A, He J . The global epidemiology of hypertension. Nat Rev Nephrol. 2020; 16(4):223-237. PMC: 7998524. DOI: 10.1038/s41581-019-0244-2. View

Hierons S, Marsh J, Wu D, Blindauer C, Stewart A . The Interplay between Non-Esterified Fatty Acids and Plasma Zinc and Its Influence on Thrombotic Risk in Obesity and Type 2 Diabetes. Int J Mol Sci. 2021; 22(18). PMC: 8471329. DOI: 10.3390/ijms221810140. View

Watanabe S, Tagawa T, Yamakawa K, Shimabukuro M, Ueda S . Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol. 2005; 25(11):2376-80. DOI: 10.1161/01.ATV.0000187465.55507.85. View

Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm B . Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab. 2006; 91(7):2542-7. DOI: 10.1210/jc.2006-0195. View

Azekoshi Y, Yasu T, Watanabe S, Tagawa T, Abe S, Yamakawa K . Free fatty acid causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin II production in mononuclear and polymorphonuclear cells. Hypertension. 2010; 56(1):136-42. DOI: 10.1161/HYPERTENSIONAHA.110.153056. View

10.

Pilz S, Scharnagl H, Tiran B, Wellnitz B, Seelhorst U, Boehm B . Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography. Eur Heart J. 2007; 28(22):2763-9. DOI: 10.1093/eurheartj/ehm343. View

11.

Ettehad D, Emdin C, Kiran A, Anderson S, Callender T, Emberson J . Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016; 387(10022):957-967. DOI: 10.1016/S0140-6736(15)01225-8. View

12.

Egan B, Hennes M, Stepniakowski K, OShaughnessy I, Kissebah A, Goodfriend T . Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension. 1996; 27(3 Pt 2):723-8. DOI: 10.1161/01.hyp.27.3.723. View

13.

Martchenko A, Brubaker P . Effects of Obesogenic Feeding and Free Fatty Acids on Circadian Secretion of Metabolic Hormones: Implications for the Development of Type 2 Diabetes. Cells. 2021; 10(9). PMC: 8466112. DOI: 10.3390/cells10092297. View

14.

Myers M, McPhail L, Snyderman R . Redistribution of protein kinase C activity in human monocytes: correlation with activation of the respiratory burst. J Immunol. 1985; 135(5):3411-6. View

15.

Pereira S, Park E, Mori Y, Haber C, Han P, Uchida T . FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress. Am J Physiol Endocrinol Metab. 2014; 307(1):E34-46. PMC: 4080148. DOI: 10.1152/ajpendo.00436.2013. View

16.

Porte Jr D . Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. Diabetes Metab Res Rev. 2001; 17(3):181-8. DOI: 10.1002/1520-7560(200105/06)17:3<181::aid-dmrr197>3.0.co;2-1. View

17.

. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

18.

Charles M, Fontbonne A, Thibult N, Claude J, Warnet J, Rosselin G . High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris Prospective Study. Am J Epidemiol. 2001; 153(3):292-8. DOI: 10.1093/aje/153.3.292. View

19.

Lipke K, Kubis-Kubiak A, Piwowar A . Molecular Mechanism of Lipotoxicity as an Interesting Aspect in the Development of Pathological States-Current View of Knowledge. Cells. 2022; 11(5). PMC: 8909283. DOI: 10.3390/cells11050844. View

20.

Liu H, Cao Y, Jin J, Hua Q, Li Y, Guo Y . Lipoprotein (a), hypertension, and cardiovascular outcomes: a prospective study of patients with stable coronary artery disease. Hypertens Res. 2021; 44(9):1158-1167. DOI: 10.1038/s41440-021-00668-4. View